This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Yoko Yamaki: Innovator in Pharmaceutical Composition
Introduction
Yoko Yamaki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating AXL-related cancers. With a total of 2 patents, her work is paving the way for innovative cancer therapies.
Latest Patents
Yoko's latest patents focus on a pharmaceutical composition comprising diamino heterocyclic carboxamide compounds as active ingredients. These compositions are designed to treat cancers that exhibit high expression of AXL or have developed resistance to anticancer agents through AXL activation. The specific compounds she has developed demonstrate AXL inhibitory action, providing therapeutic effects on AXL-related cancers.
Career Highlights
Yoko Yamaki is currently employed at Astellas Pharma GmbH, where she continues to advance her research in pharmaceutical innovations. Her work is crucial in addressing the challenges posed by AXL-related cancers, which are often difficult to treat due to their resistance mechanisms.
Collaborations
Yoko collaborates with esteemed colleagues such as Tomohiro Eguchi and Masamichi Mori. Their combined expertise enhances the research and development efforts at Astellas Pharma GmbH.
Conclusion
Yoko Yamaki's contributions to pharmaceutical compositions represent a significant advancement in cancer treatment. Her innovative work continues to inspire and drive progress in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile